Organic Process Research & Development
Article
7.16−7.25 (m, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ
13.9, 19.0, 38.7, 61.7, 64.2, 125.6, 126.7, 127.4, 127.7, 128.5,
129.6, 130.1, 134.6, 136.2, 138.3, 170.4.
C19H21NO4: C, 69.71; H, 6.47; N, 4.28. Found: C, 69.83; H,
6.49; N, 4.29.
Diethyl 2-Methyl-2-(pyridin-4-ylmethyl)malonate
(3hc). The procedure was followed with the use of 1h (168
mg, 1.0 mmol) and 2c (182 mg, 1.0 mmol). The reaction was
carried out for 24 h. The crude product was purified with flash
column chromatography (EtOAc/hexane = 2/1) to give 3hc
(227 mg, 85%) as a colorless oil. 1H NMR (400 MHz, CDCl3,
TMS): δ 1.22 (t, J = 7.2 Hz, 6H), 1.35 (s, 3H), 3.21 (s, 2H),
4.20 (q, J = 7.2 Hz, 4H), 7.08 (d, J = 5.9 Hz, 2H), 8.50 (d, J =
5.9 Hz, 2H). 13C{1H} NMR (101 MHz, CDCl3): δ 13.9, 19.7,
40.4, 54.2, 61.5, 125.4, 145.3, 149.5, 171.3. Anal. Calcd for
C14H19NO4: C, 63.38; H, 7.22; N, 5.28. Found: C, 63.05; H,
7.29; N, 5.23.
Diethyl 2-(4-Methoxybenzyl)-2-methylmalonate
(3bc). See ref 13b. The procedure was followed with the use
of 1b (197 mg, 1.0 mmol) and diethyl 2-methylmalonate (2c)
(190 mg, 1.1 mmol). The reaction was carried out for 48 h.
The crude product was purified with flash column chromatog-
raphy (EtOAc/hexane = 1/5) to give 3bc (256 mg, 87%) as a
colorless oil. 1H NMR (400 MHz, CDCl3, TMS): δ 1.25 (t, J =
7.1 Hz, 6H), 1.33 (s, 3H), 3.16 (s, 2H), 3.77 (s, 3H), 4.19 (q, J
= 7.1 Hz, 4H), 6.79 (d, J = 8.6 Hz, 2H), 7.04 (d, J = 8.6 Hz,
2H). 13C{1H} NMR (101 MHz, CDCl3): δ 14.0, 19.6, 40.2,
54.8, 55.1, 61.2, 113.5, 128.1, 131.1, 158.5, 172.0.
2-Acetyl-2-(4-methoxybenzyl)cyclohexanone (3bf).
See ref 13b. The procedure was followed with the use of 1b
(196 mg, 1.0 mmol), 2-acetylcyclohexanone 2f (140 mg, 1.1
mmol), and DCyPF (L3) (7.1 mg, 12 μmol). The reaction was
carried out at 50 °C for 24 h. The crude product was purified
with flash column chromatography (EtOAc/hexane = 1/5) to
Dimethyl 2-Methoxy-2-(4-methoxybenzyl)malonate
(3bd). See ref 13a. The procedure was followed with the use
of 1b (195 mg, 1.0 mmol) and dimethyl 2-methoxymalonate
(2d) (179 mg, 1.1 mmol). The reaction was carried out for 24
h. The crude product was purified with flash column
chromatography (EtOAc/hexane = 1/2) to give 3bd (252
1
1
give 3bf (234 mg, 90%) as a pale yellow oil. H NMR (400
mg, 90%) as a pale yellow oil. H NMR (400 MHz, CDCl3,
MHz, CDCl3, TMS): δ 1.42 (ddd, J = 4.3, 12.4, 13.8 Hz, 1H),
1.54−1.77 (m, 3H), 1.91−2.01 (m, 1H), 2.09 (s, 3H), 2.24
(ddd, J = 6.0, 12.6, 14.1 Hz, 1H), 2.32−2.39 (m, 1H), 2.46−
2.54 (m, 1H), 3.03 (d, J = 14.2 Hz, 1H), 3.09 (d, J = 14.2 Hz,
1H), 3.77 (s, 3H), 6.67 (d, J = 8.7 Hz, 2H), 6.99 (d, J = 8.7
Hz, 2H). 13C{1H} NMR (101 MHz, CDCl3): δ 22.2, 26.8,
27.0, 33.9, 39.1, 42.1, 55.1, 68.8, 113.6, 128.0, 131.2, 158.4,
205.9, 209.6.
Ethyl 1-(4-Methoxybenzyl)-2-oxocyclohexanecarbox-
ylate (3bg). See ref 13b. The procedure was followed with the
use of 1b (196 mg, 1.0 mmol), ethyl 2-oxocyclohexanecarbox-
ylate 2g (188 mg, 1.1 mmol), and L3 (6.6 mg, 11 μmol). The
reaction was carried out at 50 °C for 120 h. The crude product
was purified with flash column chromatography (EtOAc/
hexane = 1/5) to give 3bg (221 mg, 76%) as a colorless solid.
1H NMR (400 MHz, CDCl3, TMS): δ 1.19 (t, J = 7.12 Hz,
3H), 1.44 (ddd, J = 5.0, 11.7, 13.6 Hz, 1H), 1.54−1.78 (m,
3H), 1.95−2.05 (m, 1H), 2.36−2.51 (m, 3H), 2.83 (d, J = 13.9
Hz, 1H), 3.23 (d, J = 13.9 Hz, 1H), 3.77 (s, 3H), 4.08 (dq, J =
10.8, 7.1 Hz, 1H), 4.13 (dq, J = 10.8, 7.1 Hz, 1H), 6.77 (d, J =
8.7 Hz, 2H), 7.03 (d, J = 8.7 Hz, 2H). 13C{1H} NMR (101
MHz, CDCl3): δ 14.0, 22.5, 27.6, 35.8, 39.5, 41.3, 55.2, 61.2,
62.2, 113.4, 128.5, 131.3, 158.3, 171.1, 207.5.
TMS): δ 3.29 (s, 2H), 3.45 (s, 3H), 3.73 (s, 6H), 3.74 (s, 3H),
6.78 (d, J = 8.1 Hz, 2H), 7.09 (d, J = 8.1 Hz, 2H). 13C{1H}
NMR (101 MHz, CDCl3): δ 38.1, 53.0, 53.8, 54.8, 85.6, 113.4,
126.2, 130.8, 158.4, 168.4.
Diethyl 2-(Acetylamino)-2-(4-methoxybenzyl)-
malonate (3be). See ref 13a. The procedure was followed
with the use of 1b (193 mg, 0.98 mmol) and diethyl 2-
(acetylamino)malonate (2e) (243 mg, 1.1 mmol). The
reaction was carried out in DMF (3.0 mL) for 72 h. The
crude product was purified with flash column chromatography
(EtOAc/hexane = 1/1) to give 3be (312 mg, 95%) as a
colorless solid. 1H NMR (400 MHz, CDCl3, TMS): δ 1.29 (t, J
= 7.1 Hz, 6H), 2.03 (s, 3H), 3.59 (s, 2H), 3.77 (s, 3H), 4.25
(dq, J = 10.7, 7.1 Hz, 2H), 4.28 (dq, J = 10.7, 7.1 Hz, 2H),
6.53 (br s, 1H), 6.79 (d, J = 8.6 Hz, 2H), 6.92 (d, J = 8.6 Hz,
2H). 13C{1H} NMR (101 MHz, CDCl3): δ 14.0, 23.0, 36.9,
55.1, 62.5, 67.3, 113.7, 127.1, 130.8, 158.7, 167.6, 169.0.
Diethyl 2-Phenyl-2-(pyridin-3-ylmethyl)malonate
(3gb). The procedure was followed with the use of methyl
pyridin-3-ylmethyl carbonate (1g) (166 mg, 0.99 mmol) and
2b (260 mg, 1.1 mmol). The reaction was carried out for 48 h.
The crude product was purified with flash column chromatog-
raphy (EtOAc/hexane = 1/1) to give 3gb (303 mg, 94%) as a
pale yellow oil. 1H NMR (400 MHz, CDCl3, TMS): δ 1.21 (t,
J = 7.0 Hz, 6H), 3.58 (s, 2H), 4.21 (q, J = 7.0 Hz, 4H), 7.06
(dd, J = 4.8, 7.8 Hz, 1H), 7.18−7.31 (m, 6H), 8.14 (d, J = 1.8
Hz, 1H), 8.40 (d, J = 4.8 Hz, 1H). 13C{1H} NMR (101 MHz,
CDCl3): δ 13.9, 40.2, 61.8, 64.1, 122.6, 127.7, 128.1, 131.8,
136.6, 137.8, 148.1, 151.6, 169.8. Anal. Calcd for C19H21NO4:
C, 69.71; H, 6.47; N, 4.28. Found: C, 69.81; H, 6.41; N, 4.28.
Diethyl 2-Phenyl-2-(pyridin-4-ylmethyl)malonate
(3hb). The procedure was followed with the use of methyl
pyridin-4-ylmethyl carbonate (1h) (164 mg, 0.98 mmol) and
2b (260 mg, 1.1 mmol). The reaction was carried out for 24 h.
The crude product was purified with flash column chromatog-
raphy (EtOAc/hexane = 1/1) to give 3hb (303 mg, 94%) as a
pale yellow oil. 1H NMR (400 MHz, CDCl3, TMS): δ 1.20 (t,
J = 7.1 Hz, 6H), 3.59 (s, 2H), 4.21 (q, J = 7.1 Hz, 4H), 6.84 (d,
J = 5.9 Hz, 2H), 7.22−7.31 (m, 5H), 8.37 (d, J = 5.9 Hz, 2H).
13C{1H} NMR (101 MHz, CDCl3): δ 13.8, 42.0, 61.9, 63.6,
125.6, 127.7, 128.1, 136.4, 145.3, 149.2, 169.7. Anal. Calcd for
Reaction of L2−Palladium(0) 5 with 1a (Scheme 1,
Equation 1). In a nitrogen-filled dry-box, Pd(η3-C3H5)(Cp)
(3.1 mg, 15 μmol) and L2 (6.5 mg, 16 μmol) were dissolved in
THF-d8 (0.7 mL) in a vial. The resulting solution was
transferred into a screw-capped NMR tube. The tube was
sealed with a cap containing a septum and then removed from
the dry-box. The solution was analyzed with NMR measure-
ments. Benzyl ester 1a (3.2 mg, 19 μmol) was added to the
1
solution which was then mixed well with shaking. Its H,
1H{31P}, and 31P{1H} NMR spectra were observed after 5 min
and 1, 2, 3, 6, and 18 h.
Reaction of 5, 1a, and Silver Tetrakis[3,5-bis-
(trifluoromethyl)phenyl]borate (AgBARF) (Scheme 1,
Equation 2). Under a nitrogen atmosphere, a solution of
Pd(η3-C3H5)(Cp) (4.3 mg, 20 μmol) and L2 (8.8 mg, 21
μmol) in dry THF (0.5 mL) was stirred for 10 min. Benzyl
ester 1a (16.7 mg, 0.10 mmol) was added to the solution. After
2 h, AgBARF (21.3 mg, 22 μmol) was added to the mixture.
After 15 min, the solvent was removed in vacuo. The residue
I
Org. Process Res. Dev. XXXX, XXX, XXX−XXX